JP2002513748A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002513748A5 JP2002513748A5 JP2000546752A JP2000546752A JP2002513748A5 JP 2002513748 A5 JP2002513748 A5 JP 2002513748A5 JP 2000546752 A JP2000546752 A JP 2000546752A JP 2000546752 A JP2000546752 A JP 2000546752A JP 2002513748 A5 JP2002513748 A5 JP 2002513748A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- weight
- acid
- phospholipid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims description 18
- 239000008194 pharmaceutical composition Substances 0.000 claims 11
- 239000000126 substance Substances 0.000 claims 9
- 150000003904 phospholipids Chemical class 0.000 claims 6
- 235000014113 dietary fatty acids Nutrition 0.000 claims 4
- 239000000194 fatty acid Substances 0.000 claims 4
- 150000004665 fatty acids Chemical class 0.000 claims 4
- 239000002904 solvent Substances 0.000 claims 3
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butanoic acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 claims 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N Decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 claims 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N Hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 claims 2
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 claims 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N Oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 2
- ZAKBPRIDLSBYQQ-VHSXEESVSA-N 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol) Chemical class CC(=O)OC[C@@H](OC(C)=O)COP(O)(=O)OC[C@@H](O)CO ZAKBPRIDLSBYQQ-VHSXEESVSA-N 0.000 claims 1
- DVZARZBAWHITHR-GOSISDBHSA-O 1,2-dicaproyl-sn-glycero-3-phosphocholine Chemical compound CCCCCC(=O)OC[C@@H](OC(=O)CCCCC)COP(O)(=O)OCC[N+](C)(C)C DVZARZBAWHITHR-GOSISDBHSA-O 0.000 claims 1
- 229940116904 ANTIINFLAMMATORY THERAPEUTIC RADIOPHARMACEUTICALS Drugs 0.000 claims 1
- 229940064005 Antibiotic throat preparations Drugs 0.000 claims 1
- 229940083879 Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE Drugs 0.000 claims 1
- 229940042052 Antibiotics for systemic use Drugs 0.000 claims 1
- 229940042786 Antitubercular Antibiotics Drugs 0.000 claims 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 claims 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 claims 1
- 229940093922 Gynecological Antibiotics Drugs 0.000 claims 1
- 229960005015 Local anesthetics Drugs 0.000 claims 1
- 229940083877 Local anesthetics for treatment of hemorrhoids and anal fissures for topical use Drugs 0.000 claims 1
- 235000021360 Myristic acid Nutrition 0.000 claims 1
- 229940074726 OPHTHALMOLOGIC ANTIINFLAMMATORY AGENTS Drugs 0.000 claims 1
- 239000005642 Oleic acid Substances 0.000 claims 1
- 229940067631 Phospholipids Drugs 0.000 claims 1
- 239000002202 Polyethylene glycol Substances 0.000 claims 1
- 229940024982 Topical Antifungal Antibiotics Drugs 0.000 claims 1
- FVJZSBGHRPJMMA-IOLBBIBUSA-N [(2R)-2,3-bis(octadecanoyloxy)propoxy][(2S)-2,3-dihydroxypropoxy]phosphinic acid Chemical class CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@@H](O)CO)OC(=O)CCCCCCCCCCCCCCCCC FVJZSBGHRPJMMA-IOLBBIBUSA-N 0.000 claims 1
- 239000003242 anti bacterial agent Substances 0.000 claims 1
- 239000002260 anti-inflammatory agent Substances 0.000 claims 1
- 239000003429 antifungal agent Substances 0.000 claims 1
- 239000008346 aqueous phase Substances 0.000 claims 1
- 230000003115 biocidal Effects 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 125000004432 carbon atoms Chemical group C* 0.000 claims 1
- 150000001735 carboxylic acids Chemical class 0.000 claims 1
- 201000009910 diseases by infectious agent Diseases 0.000 claims 1
- 239000012530 fluid Substances 0.000 claims 1
- 238000001879 gelation Methods 0.000 claims 1
- 239000008350 hydrogenated phosphatidyl choline Substances 0.000 claims 1
- 238000010348 incorporation Methods 0.000 claims 1
- 239000003112 inhibitor Substances 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 229940079866 intestinal antibiotics Drugs 0.000 claims 1
- 238000010255 intramuscular injection Methods 0.000 claims 1
- 239000007927 intramuscular injection Substances 0.000 claims 1
- 239000003589 local anesthetic agent Substances 0.000 claims 1
- 229940064003 local anesthetic throat preparations Drugs 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000002480 mineral oil Substances 0.000 claims 1
- 235000010446 mineral oil Nutrition 0.000 claims 1
- 229960002446 octanoic acid Drugs 0.000 claims 1
- 229940005935 ophthalmologic Antibiotics Drugs 0.000 claims 1
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 claims 1
- 150000008105 phosphatidylcholines Chemical class 0.000 claims 1
- 229910052698 phosphorus Inorganic materials 0.000 claims 1
- 239000011574 phosphorus Substances 0.000 claims 1
- -1 phosphorus lipid Chemical class 0.000 claims 1
- 229920001223 polyethylene glycol Polymers 0.000 claims 1
- 239000000243 solution Substances 0.000 claims 1
- 238000003756 stirring Methods 0.000 claims 1
- 238000010254 subcutaneous injection Methods 0.000 claims 1
- 239000007929 subcutaneous injection Substances 0.000 claims 1
- 150000003626 triacylglycerols Chemical class 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 description 7
- 238000009472 formulation Methods 0.000 description 6
- 210000002966 Serum Anatomy 0.000 description 2
- 210000004369 Blood Anatomy 0.000 description 1
- 210000003462 Veins Anatomy 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
Description
【0045】
例2 放出テスト
例1で製造した製剤A2およびB1を、0.83s -1 (50rpm)で回転するパドルで37℃の温度において機械No.1を用いて、米国薬局方(Pharmacopea)の第23版(USP23)中の基準に従って行われる放出テストに供した。
このテストは、製剤A2が6時間で活性成分の約60%を放出し、その放出が次いでゆっくりと続いて24時間で約65%に到達することを示した。製剤B1に関しては、それは、6時間で約45%の活性成分を放出し、次いで、放出がゆっくりと続いて24時間で約55%に到達する。
例2 放出テスト
例1で製造した製剤A2およびB1を、0.83s -1 (50rpm)で回転するパドルで37℃の温度において機械No.1を用いて、米国薬局方(Pharmacopea)の第23版(USP23)中の基準に従って行われる放出テストに供した。
このテストは、製剤A2が6時間で活性成分の約60%を放出し、その放出が次いでゆっくりと続いて24時間で約65%に到達することを示した。製剤B1に関しては、それは、6時間で約45%の活性成分を放出し、次いで、放出がゆっくりと続いて24時間で約55%に到達する。
【0046】
2.2 例1で製造した製剤Z1〜Z5を、0.83s -1 (50rpm)で回転するパドルで37℃の温度において機械No.1を用いて、米国薬局方の第23版(USP23)中の基準に従って行われる放出テストに供した。
このテストは、製剤Z5が24時間で活性成分の約23%を放出し、その放出が次いで続いて48時間で約31%に到達した;製剤Z3が24時間で活性成分の約18%を放出し;製剤Z1が24時間で活性成分の約14%を放出し;製剤Z2およびZ4が24時間で活性成分の約7%を放出することを示した。これらの結果は、製剤の組成物を修正することによって、活性成分の放出に影響させることが可能なことを示す。
2.2 例1で製造した製剤Z1〜Z5を、0.83s -1 (50rpm)で回転するパドルで37℃の温度において機械No.1を用いて、米国薬局方の第23版(USP23)中の基準に従って行われる放出テストに供した。
このテストは、製剤Z5が24時間で活性成分の約23%を放出し、その放出が次いで続いて48時間で約31%に到達した;製剤Z3が24時間で活性成分の約18%を放出し;製剤Z1が24時間で活性成分の約14%を放出し;製剤Z2およびZ4が24時間で活性成分の約7%を放出することを示した。これらの結果は、製剤の組成物を修正することによって、活性成分の放出に影響させることが可能なことを示す。
【0070】
300μLの血液サンプルを、投与の前(t=0)に、および投与後の時間:30分、1時間、2時間、4時間、8時間、24時間、32時間および48時間で、尾静脈から採取する。それらのサンプルを、100s -1 (6000rpm)で10分間の逐次的な2遠心を経る前に、室温で1時間放置する。血清カルシウムのアッセイ時まで採取した血清を−20℃で凍結する。
300μLの血液サンプルを、投与の前(t=0)に、および投与後の時間:30分、1時間、2時間、4時間、8時間、24時間、32時間および48時間で、尾静脈から採取する。それらのサンプルを、100s -1 (6000rpm)で10分間の逐次的な2遠心を経る前に、室温で1時間放置する。血清カルシウムのアッセイ時まで採取した血清を−20℃で凍結する。
Claims (14)
- 少なくとも1つの活性物質のコントロールされた放出を与える流体の薬剤組成物であって、
a)少なくとも1つの活性物質の治療的に有効な量、
b)3〜55質量%(重量%)のリン脂質、
c)16〜72質量%(重量%)の薬学的に許容可能な溶媒、および
d)4〜52質量%(重量%)の脂肪酸を含み、
水相の存在下で瞬時にゲル化する性質を有する組成物。 - 前記活性物質が、抗生物質、感染防止剤、局所麻酔剤、消炎剤、抗真菌薬およびペプチド活性物質から選ばれることを特徴とする請求項1に従う薬剤組成物。
- 前記リン脂質が、単独または混合物としての、ホスファチジルコリン、ホスファチジルグリセロール塩、ジカプロイルホスファチジルコリンおよびジステアロイルホスファチジルグリセロール塩から選ばれることを特徴とする請求項1および2のいずれかに従う薬剤組成物。
- それが、15〜55質量%(重量%)のリン脂質を含むことを特徴とする請求項3に従う薬剤組成物。
- 前記リン脂質が、水素化されたホスファチジルコリンであることを特徴とする請求項1および2のいずれかに従う薬剤組成物。
- それが、3〜11質量%(重量%)のリン脂質を含むことを特徴とする請求項5に従う薬剤組成物。
- 前記薬学的に許容可能な溶媒が、単独または混合物としての、プロピレングリコール、ポリエチレングリコール、および鉱油から選ばれる請求項1〜6のいずれか1つに従うことを特徴とする薬剤組成物。
- 用いられた前記脂肪酸が、4〜22個の炭素原子を含む飽和または不飽和有機カルボン酸であることを特徴とする請求項1〜7のいずれかに従う薬剤組成物。
- 前記脂肪酸が、単独または混合物としての、オレイン酸、カプリル酸、カプリン酸、カプロン酸、ミリスチン酸および酪酸から選ばれることを特徴とする請求項8に従う薬剤組成物。
- それが、5質量%(重量%)までのモノグリセリドまたはジグリセリド、またはモノ−およびジグリセリドの混合物、および/又は15質量%(重量%)までのトリグリセリドをも含むことを特徴とする請求項1〜9のいずれかに従う薬剤組成物。
- 請求項1〜10のいずれか1つに従う薬剤組成物を製造する方法であって、
i)1以上のリン脂質を薬学的に許容可能な溶媒に溶解し;
ii)1以上の脂肪酸を、そのリン脂質溶液に攪拌しつつ加え;
iii)1以上の活性物質を、ステップii)の終わりで得られる混合物に取り込み、および
iv)ステップiii)で得られた組成物に、所望により水を加える;
の逐次的なステップを含むことを特徴とする方法。 - 前記1以上の活性物質が、ステップiii)で取込みの前に、最小量の水に溶解されることを特徴とする請求項11に従う方法。
- 前記1以上の活性物質が、ステップiii)で、所望によりミクロ化された形で取込まれることを特徴とする請求項11に従う方法。
- 活性物質の皮下および/又は筋肉内注射による1以上の活性物質のコントロールされた放出のための請求項1〜13のいずれか1つに従う組成物の使用。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BE9800329A BE1011899A6 (fr) | 1998-04-30 | 1998-04-30 | Compositions pharmaceutiques gelifiables utilisables. |
BE09800329 | 1998-04-30 | ||
PCT/EP1999/002551 WO1999056725A1 (fr) | 1998-04-30 | 1999-04-16 | Compositions pharmaceutiques gelifiables |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2002513748A JP2002513748A (ja) | 2002-05-14 |
JP2002513748A5 true JP2002513748A5 (ja) | 2005-08-18 |
Family
ID=3891230
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2000546752A Pending JP2002513748A (ja) | 1998-04-30 | 1999-04-16 | ゲル化性薬剤組成物 |
JP2000546753A Withdrawn JP2002513749A (ja) | 1998-04-30 | 1999-04-16 | 歯根療法へのゲル化できる医薬組成物の使用 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2000546753A Withdrawn JP2002513749A (ja) | 1998-04-30 | 1999-04-16 | 歯根療法へのゲル化できる医薬組成物の使用 |
Country Status (26)
Country | Link |
---|---|
US (3) | US6464987B1 (ja) |
EP (2) | EP1073414B1 (ja) |
JP (2) | JP2002513748A (ja) |
KR (1) | KR100567975B1 (ja) |
CN (1) | CN1183901C (ja) |
AT (2) | ATE307569T1 (ja) |
AU (2) | AU3708599A (ja) |
BE (1) | BE1011899A6 (ja) |
BG (1) | BG64723B1 (ja) |
BR (1) | BR9910066A (ja) |
CA (1) | CA2330500C (ja) |
DE (2) | DE69901951T2 (ja) |
DK (1) | DK1073415T3 (ja) |
EA (1) | EA002530B1 (ja) |
ES (2) | ES2249891T3 (ja) |
HK (1) | HK1033263A1 (ja) |
HU (1) | HU226556B1 (ja) |
ID (1) | ID26221A (ja) |
IL (1) | IL139113A0 (ja) |
IS (1) | IS2354B (ja) |
NO (1) | NO20005431L (ja) |
NZ (1) | NZ507707A (ja) |
RS (1) | RS50025B (ja) |
TR (1) | TR200003158T2 (ja) |
WO (2) | WO1999056726A1 (ja) |
ZA (1) | ZA200005915B (ja) |
Families Citing this family (152)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE1011899A6 (fr) * | 1998-04-30 | 2000-02-01 | Ucb Sa | Compositions pharmaceutiques gelifiables utilisables. |
US11026768B2 (en) | 1998-10-08 | 2021-06-08 | Align Technology, Inc. | Dental appliance reinforcement |
DE10024413A1 (de) * | 2000-05-19 | 2001-12-06 | Mika Pharma Gmbh | Pharmazeutische und/oder kosmetische Zubereitung |
DE10057769A1 (de) | 2000-11-22 | 2002-05-23 | Beiersdorf Ag | Haarpflegeprodukte mit einem Gehalt an dispersen Flüssigkristallen, welche kubische Phasen darstellen |
US6946137B2 (en) * | 2001-10-19 | 2005-09-20 | Idexx Laboratories, Inc. | Methods for the controlled delivery of pharmacologically active compounds |
AU2002335077B2 (en) * | 2001-10-19 | 2006-09-07 | Idexx Laboratories, Inc. | Injectable compositions for the controlled delivery of pharmacologically active compound |
FR2837099B1 (fr) * | 2002-03-12 | 2005-03-18 | Ethypharm Sa | Composition a proprietes gelifiantes destinee a la delivrance prolongee de substances bio-actives |
US7691408B2 (en) * | 2002-03-12 | 2010-04-06 | Ethypharm | Composition having gelling properties for the prolonged delivery of bioactive substances |
US20040018237A1 (en) | 2002-05-31 | 2004-01-29 | Perricone Nicholas V. | Topical drug delivery using phosphatidylcholine |
US8435942B2 (en) * | 2002-05-31 | 2013-05-07 | Transdermal Biotechnology, Inc. | Methods for formulating stabilized insulin compositions |
US20050031650A1 (en) * | 2002-08-26 | 2005-02-10 | Ethypharm | Composition with gelling properties for the sustained delivery of bioactive substances |
DE10255195A1 (de) * | 2002-11-27 | 2004-06-09 | Lipoid Gmbh | Micellare wasserlösliche Konzentrate |
US8865021B2 (en) | 2003-11-07 | 2014-10-21 | Camurus Ab | Compositions of lipids and cationic peptides |
WO2006075124A1 (en) * | 2005-01-14 | 2006-07-20 | Camurus Ab | Somatostatin analogue formulations |
US20070232695A1 (en) * | 2004-01-28 | 2007-10-04 | Collegium Pharmaceutical, Inc. | Gelled Periodontal Anesthetic Preparation |
US9492245B2 (en) | 2004-02-27 | 2016-11-15 | Align Technology, Inc. | Method and system for providing dynamic orthodontic assessment and treatment profiles |
DE602005008247D1 (de) * | 2004-06-04 | 2008-08-28 | Camurus Ab | Flüssige depotformulierungen |
GB0412530D0 (en) * | 2004-06-04 | 2004-07-07 | Camurus Ab | Formulation |
US7858115B2 (en) * | 2004-06-24 | 2010-12-28 | Idexx Laboratories | Phospholipid gel compositions for drug delivery and methods of treating conditions using same |
AU2005302554A1 (en) * | 2004-10-28 | 2006-05-11 | Idexx Laboratories, Inc. | Compositions for controlled delivery of pharmaceutically active compounds |
US20060115782A1 (en) * | 2004-11-30 | 2006-06-01 | Chunhua Li | Systems and methods for coating a dental appliance |
US20060115785A1 (en) | 2004-11-30 | 2006-06-01 | Chunhua Li | Systems and methods for intra-oral drug delivery |
US20070059350A1 (en) * | 2004-12-13 | 2007-03-15 | Kennedy John P | Agents for controlling biological fluids and methods of use thereof |
US20060127437A1 (en) * | 2004-12-13 | 2006-06-15 | Misty Anderson Kennedy | Semisolid system and combination semisolid, multiparticulate system for sealing tissues and/or controlling biological fluids |
EP2206495B1 (en) * | 2005-01-14 | 2012-11-21 | Camurus AB | Topical bioadhesive formulations |
US8871712B2 (en) * | 2005-01-14 | 2014-10-28 | Camurus Ab | Somatostatin analogue formulations |
US9649382B2 (en) * | 2005-01-14 | 2017-05-16 | Camurus Ab | Topical bioadhesive formulations |
CA2594718C (en) * | 2005-01-14 | 2012-01-24 | Camurus Ab | Gnrh analogue formulations |
US9060935B2 (en) * | 2005-01-21 | 2015-06-23 | Camurus Ab | Pharmaceutical lipid compositions |
US8546326B2 (en) * | 2005-06-06 | 2013-10-01 | Camurus Ab | Glp-1 analogue formulations |
SE531318C2 (sv) * | 2007-02-22 | 2009-02-24 | Tigran Technologies Ab Publ | Injicerbar suspension innefattande titan-,titanlegerings- eller titanoxidpartiklar av mikrostruktur |
US7878805B2 (en) | 2007-05-25 | 2011-02-01 | Align Technology, Inc. | Tabbed dental appliance |
GB0711656D0 (en) | 2007-06-15 | 2007-07-25 | Camurus Ab | Formulations |
GB0716385D0 (en) | 2007-08-22 | 2007-10-03 | Camurus Ab | Formulations |
CA2698628A1 (fr) * | 2007-09-12 | 2009-04-16 | Galderma Research & Development | Utilisation d'excipients en tant que conservateurs et composition pharmaceutique les comprenant |
US8738394B2 (en) | 2007-11-08 | 2014-05-27 | Eric E. Kuo | Clinical data file |
FR2926996B1 (fr) | 2008-01-31 | 2013-06-21 | Ethypharm Sa | Composition pharmaceutique a proprietes gelifiantes contenant un derive de tyrosine |
US8108189B2 (en) | 2008-03-25 | 2012-01-31 | Align Technologies, Inc. | Reconstruction of non-visible part of tooth |
US8092215B2 (en) | 2008-05-23 | 2012-01-10 | Align Technology, Inc. | Smile designer |
US9492243B2 (en) | 2008-05-23 | 2016-11-15 | Align Technology, Inc. | Dental implant positioning |
US8172569B2 (en) | 2008-06-12 | 2012-05-08 | Align Technology, Inc. | Dental appliance |
GB0815435D0 (en) | 2008-08-22 | 2008-10-01 | Camurus Ab | Formulations |
WO2010033726A2 (en) | 2008-09-17 | 2010-03-25 | The Brigham And Women's Hospital, Inc. | Drug delivery composition comprising a self-assembled gelator |
US8152518B2 (en) | 2008-10-08 | 2012-04-10 | Align Technology, Inc. | Dental positioning appliance having metallic portion |
US8292617B2 (en) | 2009-03-19 | 2012-10-23 | Align Technology, Inc. | Dental wire attachment |
US20100297194A1 (en) * | 2009-04-30 | 2010-11-25 | Nathaniel Catron | Formulation for oral administration of apoptosis promoter |
US8728516B2 (en) * | 2009-04-30 | 2014-05-20 | Abbvie Inc. | Stabilized lipid formulation of apoptosis promoter |
US8362013B2 (en) * | 2009-04-30 | 2013-01-29 | Abbvie Inc. | Salt of ABT-263 and solid-state forms thereof |
US20100278921A1 (en) * | 2009-04-30 | 2010-11-04 | Fischer Cristina M | Solid oral formulation of abt-263 |
US20100280031A1 (en) * | 2009-04-30 | 2010-11-04 | Paul David | Lipid formulation of apoptosis promoter |
TWI532484B (zh) * | 2009-06-08 | 2016-05-11 | 艾伯維有限公司 | 包含凋亡促進劑之固態分散劑 |
TWI540132B (zh) * | 2009-06-08 | 2016-07-01 | 亞培公司 | Bcl-2族群抑制劑之口服醫藥劑型 |
PL2387391T3 (pl) * | 2009-07-24 | 2017-09-29 | Mika Pharma Gesellschaft Für Die Entwicklung Und Vermarktung Pharmazeutischer Produkte Mbh | Sposób otrzymywania ciekłej kompozycji stosowalnej w postaci piany na skórę oraz kompozycja do aplikowania miejscowego |
US8765031B2 (en) | 2009-08-13 | 2014-07-01 | Align Technology, Inc. | Method of forming a dental appliance |
JP5779591B2 (ja) * | 2009-12-22 | 2015-09-16 | アッヴィ・インコーポレイテッド | Abt−263カプセル剤 |
RU2012138047A (ru) * | 2010-03-02 | 2014-04-10 | Имадженетикс, Инк. | Композиции, содержащие миристиновую кислоту, и их применения |
US9211166B2 (en) | 2010-04-30 | 2015-12-15 | Align Technology, Inc. | Individualized orthodontic treatment index |
US9241774B2 (en) | 2010-04-30 | 2016-01-26 | Align Technology, Inc. | Patterned dental positioning appliance |
BR112013008697A2 (pt) | 2010-09-24 | 2016-06-21 | Massachusetts Inst Technology | géis nanoestruturados capazes de liberação controlada de agentes encapsulados |
UA113500C2 (xx) | 2010-10-29 | 2017-02-10 | Одержані екструзією розплаву тверді дисперсії, що містять індукуючий апоптоз засіб | |
CA2830298C (en) | 2011-03-17 | 2016-08-16 | Transdermal Biotechnology, Inc. | Topical nitric oxide systems comprising lecithin and methods of use thereof |
US20140044779A1 (en) * | 2011-04-18 | 2014-02-13 | Lipidor Ab | Liquid Carrier for Oral Delivery of a Pharmacologically Active Agent |
US9403238B2 (en) | 2011-09-21 | 2016-08-02 | Align Technology, Inc. | Laser cutting |
US8716363B2 (en) * | 2011-09-28 | 2014-05-06 | Globus Medical, Inc. | Biodegradable putty compositions and implant devices, methods, and kits relating to the same |
BR112014013691A2 (pt) * | 2011-12-05 | 2017-06-13 | Camurus Ab | pré-formulação, métodos para distribuição de um agente ativo de peptídeo, para a preparação de uma composição cristalina líquida, de tratamento ou profilaxia de um sujeito, processo para a formação de uma pré-formulação, uso de uma mistura cristalina não líquida de baixa viscosidade, dispositivo de administração de pré-preenchido, e, kit |
CA2858356A1 (en) * | 2011-12-21 | 2013-06-27 | Hill's Pet Nutrition, Inc. | Treatment or reduction of dental conditions with ascorbyl esters |
US9375300B2 (en) | 2012-02-02 | 2016-06-28 | Align Technology, Inc. | Identifying forces on a tooth |
US9220580B2 (en) | 2012-03-01 | 2015-12-29 | Align Technology, Inc. | Determining a dental treatment difficulty |
RU2678433C2 (ru) * | 2012-05-10 | 2019-01-29 | Пейнреформ Лтд. | Депо-составы гидрофобного активного ингредиента и способы их получения |
US9414897B2 (en) | 2012-05-22 | 2016-08-16 | Align Technology, Inc. | Adjustment of tooth position in a virtual dental model |
SG11201407678YA (en) | 2012-05-25 | 2014-12-30 | Camurus Ab | Somatostatin receptor agonist formulations |
WO2014016428A1 (en) | 2012-07-26 | 2014-01-30 | Camurus Ab | Opioid formulations |
US8871260B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Methods and compositions for muscular and neuromuscular diseases |
US8871255B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Treatment of skin and soft tissue infection with nitric oxide |
US8871256B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Methods and systems for treatment of inflammatory diseases with nitric oxide |
US8871257B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery |
US8871259B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Techniques and systems for treatment of neuropathic pain and other indications |
US8871254B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system |
US8871261B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Cancer treatments and compositions for use thereof |
US8871258B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Treatment and prevention of learning and memory disorders |
US8871262B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Compositions and methods for treatment of osteoporosis and other indications |
US9241899B2 (en) | 2013-03-13 | 2016-01-26 | Transdermal Biotechnology, Inc. | Topical systems and methods for treating sexual dysfunction |
US9314422B2 (en) | 2013-03-13 | 2016-04-19 | Transdermal Biotechnology, Inc. | Peptide systems and methods for metabolic conditions |
US9320706B2 (en) | 2013-03-13 | 2016-04-26 | Transdermal Biotechnology, Inc. | Immune modulation using peptides and other compositions |
US20140271731A1 (en) | 2013-03-13 | 2014-09-18 | Transdermal Biotechnology, Inc. | Cardiovascular disease treatment and prevention |
US9295636B2 (en) | 2013-03-13 | 2016-03-29 | Transdermal Biotechnology, Inc. | Wound healing using topical systems and methods |
US9724419B2 (en) | 2013-03-13 | 2017-08-08 | Transdermal Biotechnology, Inc. | Peptide systems and methods for metabolic conditions |
US9750787B2 (en) | 2013-03-13 | 2017-09-05 | Transdermal Biotechnology, Inc. | Memory or learning improvement using peptide and other compositions |
US9314423B2 (en) | 2013-03-13 | 2016-04-19 | Transdermal Biotechnology, Inc. | Hair treatment systems and methods using peptides and other compositions |
US9295647B2 (en) | 2013-03-13 | 2016-03-29 | Transdermal Biotechnology, Inc. | Systems and methods for delivery of peptides |
US9393265B2 (en) | 2013-03-13 | 2016-07-19 | Transdermal Biotechnology, Inc. | Wound healing using topical systems and methods |
US9393264B2 (en) | 2013-03-13 | 2016-07-19 | Transdermal Biotechnology, Inc. | Immune modulation using peptides and other compositions |
US9387159B2 (en) | 2013-03-13 | 2016-07-12 | Transdermal Biotechnology, Inc. | Treatment of skin, including aging skin, to improve appearance |
US9320758B2 (en) | 2013-03-13 | 2016-04-26 | Transdermal Biotechnology, Inc. | Brain and neural treatments comprising peptides and other compositions |
US9314417B2 (en) | 2013-03-13 | 2016-04-19 | Transdermal Biotechnology, Inc. | Treatment of skin, including aging skin, to improve appearance |
US9339457B2 (en) | 2013-03-13 | 2016-05-17 | Transdermal Biotechnology, Inc. | Cardiovascular disease treatment and prevention |
US20140271938A1 (en) | 2013-03-13 | 2014-09-18 | Transdermal Biotechnology, Inc. | Systems and methods for delivery of peptides |
US9687520B2 (en) | 2013-03-13 | 2017-06-27 | Transdermal Biotechnology, Inc. | Memory or learning improvement using peptide and other compositions |
US9295637B2 (en) | 2013-03-13 | 2016-03-29 | Transdermal Biotechnology, Inc. | Compositions and methods for affecting mood states |
US9849160B2 (en) | 2013-03-13 | 2017-12-26 | Transdermal Biotechnology, Inc. | Methods and systems for treating or preventing cancer |
US20140271937A1 (en) | 2013-03-13 | 2014-09-18 | Transdermal Biotechnology, Inc. | Brain and neural treatments comprising peptides and other compositions |
US9314433B2 (en) | 2013-03-13 | 2016-04-19 | Transdermal Biotechnology, Inc. | Methods and systems for treating or preventing cancer |
US10449016B2 (en) | 2014-09-19 | 2019-10-22 | Align Technology, Inc. | Arch adjustment appliance |
US9610141B2 (en) | 2014-09-19 | 2017-04-04 | Align Technology, Inc. | Arch expanding appliance |
US9744001B2 (en) | 2014-11-13 | 2017-08-29 | Align Technology, Inc. | Dental appliance with cavity for an unerupted or erupting tooth |
US10504386B2 (en) | 2015-01-27 | 2019-12-10 | Align Technology, Inc. | Training method and system for oral-cavity-imaging-and-modeling equipment |
US9610242B2 (en) * | 2015-08-18 | 2017-04-04 | Concept Labs, Inc. | Water-gel emulsion compositions and methods |
WO2017062818A1 (en) * | 2015-10-08 | 2017-04-13 | The Brigham And Women's Hospital, Inc. | Stabilized assembled nanostructures for delivery of encapsulated agents |
US11931222B2 (en) | 2015-11-12 | 2024-03-19 | Align Technology, Inc. | Dental attachment formation structures |
US11554000B2 (en) | 2015-11-12 | 2023-01-17 | Align Technology, Inc. | Dental attachment formation structure |
US11103330B2 (en) | 2015-12-09 | 2021-08-31 | Align Technology, Inc. | Dental attachment placement structure |
US11596502B2 (en) | 2015-12-09 | 2023-03-07 | Align Technology, Inc. | Dental attachment placement structure |
US10568840B2 (en) | 2016-05-06 | 2020-02-25 | The Brigham And Women's Hospital, Inc. | Self assembled gels for controlled delivery of encapsulated agents to cartilage |
WO2017218947A1 (en) | 2016-06-17 | 2017-12-21 | Align Technology, Inc. | Intraoral appliances with sensing |
US10383705B2 (en) | 2016-06-17 | 2019-08-20 | Align Technology, Inc. | Orthodontic appliance performance monitor |
PL3578131T3 (pl) | 2016-07-27 | 2021-06-28 | Align Technology, Inc. | Skaner wewnątrzustny z możliwościami diagnostyki stomatologicznej |
US10595966B2 (en) | 2016-11-04 | 2020-03-24 | Align Technology, Inc. | Methods and apparatuses for dental images |
US11273011B2 (en) | 2016-12-02 | 2022-03-15 | Align Technology, Inc. | Palatal expanders and methods of expanding a palate |
WO2018102770A1 (en) | 2016-12-02 | 2018-06-07 | Align Technology, Inc. | Force control, stop mechanism, regulating structure of removable arch adjustment appliance |
WO2018102702A1 (en) | 2016-12-02 | 2018-06-07 | Align Technology, Inc. | Dental appliance features for speech enhancement |
CA3043049A1 (en) | 2016-12-02 | 2018-06-07 | Align Technology, Inc. | Methods and apparatuses for customizing rapid palatal expanders using digital models |
US10548700B2 (en) | 2016-12-16 | 2020-02-04 | Align Technology, Inc. | Dental appliance etch template |
US11020410B2 (en) | 2017-02-03 | 2021-06-01 | The Brigham And Women's Hospital, Inc. | Self-assembled gels formed with anti-retroviral drugs, prodrugs thereof, and pharmaceutical uses thereof |
US10779718B2 (en) | 2017-02-13 | 2020-09-22 | Align Technology, Inc. | Cheek retractor and mobile device holder |
US10613515B2 (en) | 2017-03-31 | 2020-04-07 | Align Technology, Inc. | Orthodontic appliances including at least partially un-erupted teeth and method of forming them |
EP3621594A1 (en) | 2017-05-08 | 2020-03-18 | Alivio Therapeutics, Inc. | Formulation of nanostructured gels for increased agent loading and adhesion |
US11045283B2 (en) | 2017-06-09 | 2021-06-29 | Align Technology, Inc. | Palatal expander with skeletal anchorage devices |
EP3638146A1 (en) | 2017-06-16 | 2020-04-22 | Align Technology, Inc. | Automatic detection of tooth type and eruption status |
US10639134B2 (en) | 2017-06-26 | 2020-05-05 | Align Technology, Inc. | Biosensor performance indicator for intraoral appliances |
US10885521B2 (en) | 2017-07-17 | 2021-01-05 | Align Technology, Inc. | Method and apparatuses for interactive ordering of dental aligners |
WO2019018784A1 (en) | 2017-07-21 | 2019-01-24 | Align Technology, Inc. | ANCHOR OF CONTOUR PALATIN |
WO2019023631A1 (en) | 2017-07-27 | 2019-01-31 | Align Technology, Inc. | SYSTEM AND METHODS FOR TREATING AN ORTHODONTIC ALIGNMENT USING OPTICAL COHERENCE TOMOGRAPHY |
US11633268B2 (en) | 2017-07-27 | 2023-04-25 | Align Technology, Inc. | Tooth shading, transparency and glazing |
US11116605B2 (en) | 2017-08-15 | 2021-09-14 | Align Technology, Inc. | Buccal corridor assessment and computation |
WO2019036677A1 (en) | 2017-08-17 | 2019-02-21 | Align Technology, Inc. | SURVEILLANCE OF CONFORMITY OF DENTAL DEVICE |
US10813720B2 (en) | 2017-10-05 | 2020-10-27 | Align Technology, Inc. | Interproximal reduction templates |
WO2019084326A1 (en) | 2017-10-27 | 2019-05-02 | Align Technology, Inc. | OTHER BORE ADJUSTMENT STRUCTURES |
EP3703608B1 (en) | 2017-10-31 | 2023-08-30 | Align Technology, Inc. | Determination of a dental appliance having selective occlusal loading and controlled intercuspation |
CN111315315B (zh) | 2017-11-01 | 2022-08-23 | 阿莱恩技术有限公司 | 自动治疗规划 |
WO2019100022A1 (en) | 2017-11-17 | 2019-05-23 | Align Technology, Inc. | Orthodontic retainers |
CN111417357B (zh) | 2017-11-30 | 2022-07-26 | 阿莱恩技术有限公司 | 用于监测口腔矫治器的传感器 |
WO2019118876A1 (en) | 2017-12-15 | 2019-06-20 | Align Technology, Inc. | Closed loop adaptive orthodontic treatment methods and apparatuses |
US10980613B2 (en) | 2017-12-29 | 2021-04-20 | Align Technology, Inc. | Augmented reality enhancements for dental practitioners |
CN111655191B (zh) | 2018-01-26 | 2022-04-08 | 阿莱恩技术有限公司 | 诊断性口内扫描和追踪 |
US11937991B2 (en) | 2018-03-27 | 2024-03-26 | Align Technology, Inc. | Dental attachment placement structure |
CN108498376B (zh) * | 2018-04-02 | 2020-11-13 | 榛硕(武汉)智能科技有限公司 | 一种甲基硅油乳液及其制备方法 |
CA3096417A1 (en) | 2018-04-11 | 2019-10-17 | Align Technology, Inc. | Releasable palatal expanders |
US11839605B2 (en) | 2018-10-11 | 2023-12-12 | Alivio Therapeutics, Inc. | Non-injectable hydrogel formulations for smart release |
CA3116298A1 (en) | 2018-10-15 | 2020-04-23 | Cipla Limited | Pharmaceutical formulation |
EP3848016A1 (en) * | 2020-01-08 | 2021-07-14 | 3M Innovative Properties Company | Oral care composition containing fatty acid components for treating caries |
US11992483B2 (en) | 2021-03-31 | 2024-05-28 | Cali Biosciences Us, Llc | Emulsions for local anesthetics |
JP7092922B1 (ja) | 2021-06-11 | 2022-06-28 | キユーピー株式会社 | 製剤 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5230899A (en) * | 1985-08-07 | 1993-07-27 | Smithkline Beecham Corporation | Methods and compositions for making liposomes |
US5262164A (en) * | 1989-11-17 | 1993-11-16 | The Procter & Gamble Company | Sustained release compositions for treating periodontal disease |
US5230895A (en) * | 1990-05-01 | 1993-07-27 | Copley Pharmaceutical Inc. | Sustained released delivery system for use in the periodontal pocket |
US5567456A (en) * | 1991-11-04 | 1996-10-22 | Creative Products Inc. Of Rossville | Food release compositions with organic fluidizing agents |
CA2082561A1 (en) * | 1991-11-12 | 1993-05-13 | Francis J. Leng | Antiperspirant materials and compositions |
JP3190441B2 (ja) * | 1992-07-20 | 2001-07-23 | エーザイ株式会社 | 塩酸アゼラスチンを含有する安定な製剤 |
GB9224010D0 (en) * | 1992-11-16 | 1993-01-06 | Phares Pharma Holland | Composition and method |
CA2168260C (en) * | 1993-07-28 | 2000-04-11 | Marianna Foldvari | Biphasic multilamellar lipid vesicles |
WO1996010389A1 (de) * | 1994-09-30 | 1996-04-11 | Mika Pharma Gesellschaft Für Die Entwicklung Und Vermarktung Pharmazeutischer Produkte Mbh | Pharmazeutische zusammensetzung |
US5736152A (en) | 1995-10-27 | 1998-04-07 | Atrix Laboratories, Inc. | Non-polymeric sustained release delivery system |
BE1011899A6 (fr) * | 1998-04-30 | 2000-02-01 | Ucb Sa | Compositions pharmaceutiques gelifiables utilisables. |
-
1998
- 1998-04-30 BE BE9800329A patent/BE1011899A6/fr active
-
1999
- 1999-04-16 ID IDW20002199A patent/ID26221A/id unknown
- 1999-04-16 AU AU37085/99A patent/AU3708599A/en not_active Abandoned
- 1999-04-16 CN CNB998062669A patent/CN1183901C/zh not_active Expired - Fee Related
- 1999-04-16 TR TR2000/03158T patent/TR200003158T2/xx unknown
- 1999-04-16 EP EP99919243A patent/EP1073414B1/fr not_active Expired - Lifetime
- 1999-04-16 DK DK99923418T patent/DK1073415T3/da active
- 1999-04-16 AT AT99923418T patent/ATE307569T1/de not_active IP Right Cessation
- 1999-04-16 AU AU40308/99A patent/AU738455B2/en not_active Ceased
- 1999-04-16 WO PCT/EP1999/002552 patent/WO1999056726A1/fr active IP Right Grant
- 1999-04-16 EA EA200001125A patent/EA002530B1/ru not_active IP Right Cessation
- 1999-04-16 RS YUP-666/00A patent/RS50025B/sr unknown
- 1999-04-16 EP EP99923418A patent/EP1073415B1/fr not_active Expired - Lifetime
- 1999-04-16 DE DE69901951T patent/DE69901951T2/de not_active Expired - Fee Related
- 1999-04-16 HU HU0101580A patent/HU226556B1/hu not_active IP Right Cessation
- 1999-04-16 DE DE69927963T patent/DE69927963T2/de not_active Expired - Fee Related
- 1999-04-16 ES ES99923418T patent/ES2249891T3/es not_active Expired - Lifetime
- 1999-04-16 AT AT99919243T patent/ATE219659T1/de not_active IP Right Cessation
- 1999-04-16 JP JP2000546752A patent/JP2002513748A/ja active Pending
- 1999-04-16 CA CA002330500A patent/CA2330500C/fr not_active Expired - Fee Related
- 1999-04-16 NZ NZ507707A patent/NZ507707A/en unknown
- 1999-04-16 US US09/674,159 patent/US6464987B1/en not_active Expired - Fee Related
- 1999-04-16 WO PCT/EP1999/002551 patent/WO1999056725A1/fr active IP Right Grant
- 1999-04-16 JP JP2000546753A patent/JP2002513749A/ja not_active Withdrawn
- 1999-04-16 ES ES99919243T patent/ES2178430T3/es not_active Expired - Lifetime
- 1999-04-16 BR BR9910066-5A patent/BR9910066A/pt not_active Application Discontinuation
- 1999-04-16 IL IL13911399A patent/IL139113A0/xx not_active IP Right Cessation
- 1999-04-16 KR KR1020007011844A patent/KR100567975B1/ko not_active IP Right Cessation
-
2000
- 2000-04-16 US US09/674,163 patent/US6471970B1/en not_active Expired - Fee Related
- 2000-10-17 BG BG104872A patent/BG64723B1/bg unknown
- 2000-10-17 IS IS5669A patent/IS2354B/is unknown
- 2000-10-23 ZA ZA200005915A patent/ZA200005915B/xx unknown
- 2000-10-27 NO NO20005431A patent/NO20005431L/no not_active Application Discontinuation
-
2001
- 2001-05-16 HK HK01103389A patent/HK1033263A1/xx not_active IP Right Cessation
-
2002
- 2002-09-17 US US10/259,366 patent/US6818224B2/en not_active Expired - Fee Related
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2002513748A5 (ja) | ||
JP2613750B2 (ja) | 注射可能なレシチンのゲル | |
US6464987B1 (en) | Pharmaceutical compositions capable of being gelled | |
JP4843494B2 (ja) | S/o型外用剤 | |
JP2002513749A5 (ja) | ||
PT1014946E (pt) | COMPOSIÃES ANESTéSICAS LIPOSSOMAIS DE LIBERTAÃO SUSTENTADA | |
AU763945B2 (en) | Oil-core compositions for the sustained release of hydrophobic drugs | |
US4263313A (en) | Topical pharmaceutical formulations, carrier compositions therefor, and preparation thereof | |
WO2000035456A1 (en) | Transdermal delivery system containing buprenorphine | |
JPH11512115A (ja) | 経口投与用製剤組成物 | |
JP2003503339A (ja) | 抗癌剤を含有する自己乳化システム | |
US11771708B2 (en) | Pharmaceutical carriers capable of pH dependent reconstitution and methods for making and using same | |
WO1995004551A1 (fr) | Preparation absorbable par voie percutanee | |
CA2265894A1 (en) | Pharmaceutical compositions containing amisulpride and their therapeutic applications | |
JPH0840936A (ja) | 経口投与薬物のための製剤 | |
US4837025A (en) | Self-adhesive device for the percutaneous administration of an active ingredient | |
JPH0676327B2 (ja) | ステロイド軟膏製剤 | |
RU2125446C1 (ru) | Антиглюкокортикоидное лекарственное средство | |
EP0003382B1 (en) | Solvent vehicle for therapeutics and pharmaceutical composition containing it | |
JP2022531685A (ja) | メチルナルトレキソンの液体経口投与製剤 | |
EP0930070B1 (en) | Stable aspirin ointment preparations | |
JPH09510722A (ja) | 注射可能なジリスロマイシン溶液 | |
JP2003277262A (ja) | ランソプラゾールのバイオアベイラビリティ改善技術 | |
BE867787A (fr) | Composition pharmaceutique a propriete de resorption amelioree et procede pour sa fabrication | |
JPH0637397B2 (ja) | カルシトニン類の直腸投与用組成物 |